Health care stocks were flat to higher pre-bell Thursday, with the iShares Biotechnology ETF (IBB) inactive and The Health Care Select Sector SPDR Fund (XLV) up 0.3%.
Astrazeneca (AZN) shares were up over 4% after the company reported higher Q4 earnings and revenue.
Bristol-Myers Squibb (BMY) stock was down more than 3% after the company reported a decline in Q4 non-GAAP earnings and the company issued 2025 outlook below analysts' expectations.
Eli Lilly (LLY) shares were more than 1% lower even after the company reported higher Q4 non-GAAP earnings and revenue.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.